Frontlight ResearchEarly access
Trial site
Memorial Cancer Institute
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Multiple myeloma1 trial
- Ovarian cancer1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
- Cardiff Oncology1 trial
- Celgene1 trial
- Eikon Therapeutics1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026